Additionally, differences in the tumor microenvironment are evident, with females exhibiting increased CD4+ and CD8+ T cell infiltration and distinct gene expression profiles that may influence tumor aggressiveness and therapeutic response. The gene discussed is CD4; the disease is neoplasm.